Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4713 results found.

Example of search result explained

Med-Cyproterone

Covered
  • Active ingredient(s):
    cyproterone acetate
  • Manufactured by:
    Generic Medical Partners Inc. (GMP)
  • Strength and dosage form:
    Tablet 50 mg DIN : 2390760

Riva-Cyproterone

Covered
  • Active ingredient(s):
    cyproterone acetate
  • Manufactured by:
    Laboratoire Riva Inc. (Riva)
  • Strength and dosage form:
    Tablet 50 mg DIN : 2395797

Cystadrops

Exceptional medication
  • Active ingredient(s):
    cysteamine
  • Manufactured by:
    Recordati Rare Diseases Canada Inc. (RRDC)
  • Strength and dosage form:
    Ophtalmic Solution 0.37 % DIN : 2485605

Procysbi

Exceptional medication
  • Active ingredient(s):
    cysteamine bitartrate
  • Manufactured by:
    Horizon Pharma Ireland Ltd (Horizon Ph)
  • Strength and dosage form:
    • Long Action Capsule 25 mg DIN : 2464705
    • Long Action Capsule 75 mg DIN : 2464713

Apo-Dabigatran

Exceptional medication
  • Active ingredient(s):
    dabigatran etexilate
  • Manufactured by:
    Apotex Inc. (Apotex)
  • Strength and dosage form:
    • Capsule 110 mg DIN : 2468905
    • Capsule 150 mg DIN : 2468913

Pradaxa

Exceptional medication
  • Active ingredient(s):
    dabigatran etexilate
  • Manufactured by:
    Boehringer Ingelheim (Canada) Ltée. (Bo. Ing.)
  • Strength and dosage form:
    • Capsule 110 mg DIN : 2312441
    • Capsule 150 mg DIN : 2358808

Tafinlar

Exceptional medication
  • Active ingredient(s):
    dabrafénib mesylate
  • Manufactured by:
    Novartis Pharma Canada Inc (Novartis)
  • Strength and dosage form:
    • Capsule 50 mg DIN : 2409607
    • Capsule 75 mg DIN : 2409615

Xydalba

Exceptional medication
  • Active ingredient(s):
    dalbavancin (hydrochloride)
  • Manufactured by:
    Laboratoires Paladin Inc. (Paladin)
  • Strength and dosage form:
    Intravenous or Perfusion Powder 500 mg DIN : 2480522

Fragmin

Covered
  • Active ingredient(s):
    dalteparine sodic
  • Manufactured by:
    Pfizer Canada Inc. (Pfizer)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 18 000 UI/0.72 mL DIN : 2352680
    • Subcutaneous Injectable Solution syringe 2 500 UI/0.2 mL DIN : 2132621
    • Subcutaneous Injectable Solution syringe 10 000 UI/0.4 mL DIN : 2352656
    • Subcutaneous Injectable Solution syringe 5 000 UI/0.2 mL DIN : 2132648
    • Subcutaneous Injectable Solution syringe 12 500 UI/0.5 mL DIN : 2352664
    • Subcutaneous Injectable Solution syringe 7 500 UI/0.3 ml DIN : 2352648
    • Subcutaneous Injectable Solution syringe 15 000 UI/0.6 mL DIN : 2352672
    • Subcutaneous Injectable Solution syringe 16 500 UI/0,66 mL DIN : 2494582
    • Injectable Solution 25 000 U/mL DIN : 2231171
    • Injectable Solution (syringe) 3500 UI/0,28 mL DIN : 2430789

Cyclomen

Covered
  • Active ingredient(s):
    danazol
  • Manufactured by:
    Sanofi-Aventis Canada Inc. (SanofiAven)
  • Strength and dosage form:
    • Capsule 100 mg DIN : 2018152
    • Capsule 200 mg DIN : 2018160
    • Capsule 50 mg DIN : 2018144
Page 115 of 472

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.